Melguizo Alonso, Consolación Author
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
- Raúl Ortíz
- Francisco Quiñonero
- Beatriz García-Pinel
- Marco Fuel Herrera
- Cristina Mesas
- Laura Cabeza
- Consolación Melguizo Alonso
- Jose Prados
Cancers - 1/04/2021
- JCR Impact Factor: 6.575 (2021)
- JCR 5-year Impact Factor: 6.886
- JCR Categories: ONCOLOGY
- Scopus
- ORCID
- Web of Science
Nanomedicine in Pancreatic Cancer: A New Hope for Treatment
- Redruello P.
- Perazzoli G.
- Cepero A.
- Quiñonero F.
- Mesas C.
- Doello K.
- Láinez-Ramos-bossini A.
- Rivera-Izquierdo M.
- Melguizo C.
- Prados J.
Current Drug Targets - 27/11/2020
10.2174/1389450121666200703195229
- JCR Quartile: Q2 (2020)
- JCR Impact Factor: 3.465 (2023)
- Category normalized Impact: 0.146 (2020)
- CiteScore: 5.6 (2020)
- SJR: 0.826 (2020
- SNIP: 0.909 (2020
- JCR 5-year Impact Factor: 3.758
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Nanomedicine: Application Areas and Development Prospects
- Boulaiz, Houria
- Alvarez, Pablo J.
- Ramirez, Alberto
- Marchal, Juan A.
- Prados, Jose
- Rodriguez-Serrano, Fernando
- Peran, Macarena
- Melguizo, Consolacion
- Aranega, Antonia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1/05/2011
- SJR Quartile: Q1
- JCR Impact Factor: 2.598 (2011)
- JCR 5-year Impact Factor: 2.617
- JCR Categories: CHEMISTRY, MULTIDISCIPLINARY
- SJR Categories: Computer Science Applications (Q1); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Molecular Biology (Q3)
- Scopus
- ORCID
- Web of Science
Nanoformulations for glioblastoma multiforme: A new hope for treatment
- Ortiz R.
- Cabeza L.
- Perazzoli G.
- Jimenez-Lopez J.
- García-Pinel B.
- Melguizo C.
- Prados J.
Future Medicinal Chemistry - 1/1/2019
- SJR Quartile: Q2
- JCR Impact Factor: 3.607 (2019)
- CiteScore: 5.2 (2020)
- SJR: 0.739 (2019
- SNIP: 0.802 (2019
- JCR 5-year Impact Factor: 4.065
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)
- Scopus
- ORCID
- Web of Science
Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines
- Lorente C.
- Arias J.
- Cabeza L.
- Ortiz R.
- Prados J.
- Melguizo C.
- Delgado Á.
- Clares-Naveros B.
Journal of Pharmacy and Pharmacology - 1/04/2018
- SJR Quartile: Q2
- JCR Impact Factor: 2.39 (2018)
- CiteScore: 5 (2020)
- SJR: 0.568 (2018
- SNIP: 0.79 (2018
- JCR 5-year Impact Factor: 2.728
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q2); Pharmacology (Q3)
- Scopus
- ORCID
- Web of Science
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer
- Clares B.
- Biedma-Ortiz R.
- Sáez-Fernández E.
- Prados J.
- Melguizo C.
- Cabeza L.
- Ortiz R.
- Arias J.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS - 1/1/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.245 (2013)
- CiteScore: 9 (2020)
- SJR: 1.566 (2013
- SNIP: 1.721 (2013
- JCR 5-year Impact Factor: 4.737
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Nanoemulsion strategy for ursolic and oleanic acids isolates from plumeria obtusa improves antioxidant and cytotoxic activity in melanoma cells
- Alvarado H.L.
- Calpena A.C.
- Garduño-Ramírez M.L.
- Ortiz R.
- Melguizo C.
- Prados J.C.
- Clares B.
Anti-Cancer Agents in Medicinal Chemistry - 1/1/2018
10.2174/1871520618666180111151846
- SJR Quartile: Q3
- JCR Impact Factor: 2.18 (2018)
- CiteScore: 3.5 (2020)
- SJR: 0.528 (2018
- SNIP: 0.687 (2018
- JCR 5-year Impact Factor: 2.418
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Cancer Research (Q3); Molecular Medicine (Q3); Pharmacology (Q3)
- Scopus
- ORCID
- Web of Science
Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy
- Prados, J
- Melguizo, C
- Marchal, JA
- Velez, C
- Alvarez, L
- Aranega, A
Japanese Journal of Cancer Research - 1/07/1999
10.1111/j.1349-7006.1999.tb00816.x
- JCR Quartile: Q2 (1999)
- JCR Impact Factor: 2.117 (2022)
- Category normalized Impact: 0.019 (1999)
- Scopus
- ORCID
- Web of Science
Multidrug resistance and rhabdomyosarcoma (review)
- Melguizo C.
- Prados J.
- Rama A.R.
- Ortiz R.
- Álvarez P.J.
- Fernández J.E.
- Aranega A.
Oncology Reports - 1/10/2011
- JCR Quartile: Q4 (2011)
- SJR Quartile: Q1
- JCR Impact Factor: 1.835 (2011)
- Category normalized Impact: 0.209 (2011)
- CiteScore: 6.9 (2020)
- SJR: 0.882 (2011
- SNIP: 0.681 (2011
- JCR 5-year Impact Factor: 1.827
- JCR Categories: ONCOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Oncology (Q2); Cancer Research (Q3)
- Scopus
- ORCID
- Web of Science
Morphometric study of the great arterial trunks and their branches in the human fetal heart with perimembranous ventricular septal defects
Cardiology in the Young - 1/01/1997
- CiteScore: 1.5 (2020)
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador